Venlafaxine Hydrochloride
- Product NDC
- 71610-013
- 11-digit product format
- 716100013
- Labeler code
- 71610
- Product ID
- 71610-013_f112c189-5a07-46a6-b27a-34f5f6da9a47
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- VENLAFAXINE HYDROCHLORIDE
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- NDA020699
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2011-06-02
- Marketing end
- 0000-00-00
- Substance
- VENLAFAXINE HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71610-013 | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 2 | Legacy NDC | 20190409_385d063a-970a-4e54-a99e-42271cfa861d.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71610-013-53 | 71610001353 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71610-013-53) | 2017-12-01 | 0000-00-00 | No | No | Current |
| 71610-013-79 | 71610001379 | 2160 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71610-013-79) | 2017-12-05 | 0000-00-00 | No | No | Current |